Week 17+: 2.4 mg subcutaneous once weekly (maintenance)
Dost Ongur Editor's Note by JAMA Psychiatry Editor in Chief Dost ngr, MD, PhD: In a randomized clinical trial, semaglutide reduced hemoglobin A1c and body weight and improved physical quality of life in patients with #schizophrenia, #prediabetes, and #obesity, without negative effects on mental health status
Although there have been no head-to-head trials yet, tirzepatide could potentially lead to more significant weight loss with a comparable safety profile to semaglutide, according to an article in Frontiners in Endocrinology
1994 Apr 30;343(8905):1064-8
Aim for consistent hydration throughout the day to help your body complete the process
Ling Yin, [email protected] These authors have contributed equally to this work and share first authorship Disclaimer All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers